Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
Daniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen, Dominique Maiter, Katarina Berinder, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, Gudmundur Johannsson, Charlotte Hoybye, Aart Jan van der Lely, Maria Petersson, Oskar Ragnarsson, Pia Burman
167Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide'. Sammen danner de et unikt fingeraftryk.